Actively Recruiting
Molecular Characterisation of Colorectal Cancer Peritoneal Metastases
Led by The Christie NHS Foundation Trust · Updated on 2025-01-01
200
Participants Needed
1
Research Sites
73 weeks
Total Duration
On this page
Sponsors
T
The Christie NHS Foundation Trust
Lead Sponsor
U
University of Manchester
Collaborating Sponsor
AI-Summary
What this Trial Is About
This project aims to characterise the tumour cell and tumour microenvironment of colorectal cancer peritoneal metastases, understand molecular changes leading to colorectal peritoneal metastasis, identify potential biomarkers and novel treatment strategies.
CONDITIONS
Official Title
Molecular Characterisation of Colorectal Cancer Peritoneal Metastases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients 18 years or older diagnosed with colorectal cancer and colorectal peritoneal metastases
- Have undergone cytoreductive surgery at the Christie hospital
- Availability of archived tumor tissue from both primary colorectal cancer and peritoneal metastases
You will not qualify if you...
- None
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Christie Hospital NHS Foundation Trust
Manchester, United Kingdom, M20 4BX
Actively Recruiting
Research Team
R
Richa Garvia, Ms
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here